US panel recommends new adult vaccine against hepatitis B

US panel recommends new adult vaccine against hepatitis B  Washington Post Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee  MarketWatch News of Note—AstraZeneca's FluMist, Dynavax's Heplisav-B head to ACIP  FiercePharmaFull coverage

Read More ...
US panel recommends new adult vaccine against hepatitis B published February 21, 2018 at 11:30PM. Original Source Link : https://www.washingtonpost.com/national/health-science/us-panel-recommends-new-adult-vaccine-against-hepatitis-b/2018/02/21/cfbbce04-1723-11e8-930c-45838ad0d77a_story.html

loading...